Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
30.8M
-
Shares change
-
-733K
-
Total reported value, excl. options
-
$637M
-
Value change
-
-$11.9M
-
Put/Call ratio
-
0.8
-
Number of buys
-
59
-
Number of sells
-
-63
-
Price
-
$20.70
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q3 2016
158 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q3 2016.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.8M shares
of 101M outstanding shares and own 30.52% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.51M shares), BlackRock Fund Advisors (2.17M shares), WADDELL & REED FINANCIAL INC (1.78M shares), JANUS CAPITAL MANAGEMENT LLC (1.51M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.51M shares), BlackRock Institutional Trust Company, N.A. (1.45M shares), STATE STREET CORP (1.3M shares), JPMORGAN CHASE & CO (1.08M shares), PRICE T ROWE ASSOCIATES INC /MD/ (904K shares), and FMR LLC (889K shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.